Generating market insights through primary and secondary market research, advanced analytics, and through collaboration with internal and external stakeholders.

Actively providing input for decision making as constant member of the German / Austria Leadership team. Performing month-end-close activities in collaboration with departments and EU Finance team; review of open purchase orders, completeness of accruals, review of legal entity P&L and balance sheet. Performing Budget vs. Actuals / Forecast reporting to provide insights of local business.Owning the Budget, Forecast and Long-Range-Plan for local management P&L in close collaboration with local management.

Actively providing input for decision making as constant member of the German Leadership Team.Development and monthly distribution of a key standard reporting deck for the German and French affiliate to visualize the key performance metrics.Updating units, sales and OpEx forecast for the German and French affiliate according to the FP&A planning cycle.Performing month-end-close activities in collaboration with the Regional and Global Finance team, i.e. review of open purchase orders, ensuring completeness of accruals, providing commentaries of variances vs. plan, forecasts and prior years.

Enjoyed some months of quality time: cooking, cycling, family activities, hiking, learning, meditation, stand-up paddling, teaching, traveling, and reflecting.

Supported the transition of EU Finance activities to Alexion after the acquisition of Portola Pharmaceuticals by Alexion Pharmaceuticals.Updated the EU sales forecast (long range plan, short range plan, account-based plan) as main part of the EU Region P&L based on most recent performance developments and external events.Updated, analyzed and coordinated EU OpEx budget including headcount planning to ensure appropriate resourcing and execution in the EU Region.Assessed the financial impact of Covid-19 on the EU Region and established a plan to mitigate cost run-rate for the remainder of the year.Prepared different EU P&L scenarios and proposed implementation plan to EU Management with pros and cons for each scenario.Submitted and ensured a proper integration of the EU Region P&L into the Global P&L including sales, headcount and OpEx data.Performed month-end-close activities in collaboration with the Global accounting and FP&A team, i.e. ensuring completeness of accruals, providing commentaries of variances vs. plan, forecasts and prior years.

Led the German Finance, Market Insights & Forecasting, IT and Facility team (9 direct reports; 18 employees in total) to deliver and execute on the German P&L and ensure a proper and secure infrastructure for the German affiliate.Led the 3 Years Operating Plan, forecasting and budget process of the German affiliate by collecting input from commercial, medical, market access and support functions, and ensuring the proper integration into the Corporate P&L.Led the local finance transition activities after the acquisition of Bristol-Myers Squibb by attending local integration meetings and providing financial and organizational data.

Led the re-organization of the local financial business partners and the market research & forecasting team by forming a new team within the finance organization (5 people) with dedicated focus on business units and therapeutic areas.Led all Financial Planning & Analysis activities in Germany regarding the Long-range Plan, 3-Years Operating Plan, quarterly latest estimates and the yearly budget process by compiling and consolidating relevant inputs regarding sales, OpEx and headcount data.Prepared and presented business cases regarding product launches and patent expirations, financial results and key metrics of the German affiliate to the German Management team and to the Regional Senior Management team during semi-annual business reviews.Streamlined the local forecasting process by reducing the number of business unit reviews to save time for the German General Manager, Finance Director and Business Unit heads.

Successfully managed the financial and cultural challenge from moving from a Big Pharma company to a fast-pacing Biotech company.Designed and implemented a local process for latest estimates with focus on the business unit Hematology including Sales and OpEx review. Enhanced the visibility of financial and business performance drivers versus budget, last forecasts and prior years.Provided financial input as member of several launch and brand teams by translating sales and OpEx data into meaningful decision-making proposals.Provided financial trainings to non-Finance colleagues to improve their financial knowledge which led to a higher quality of month-end closes, more solid budget management in departments and higher financial compliance of quarter-end closes.Prepared the content of the yearly management report (Lagebericht) of the Celgene GmbH in close collaboration with local stakeholders, the accounting team of the International Shared Service Center in Switzerland and external auditors.

Led the German FP&A team (4 people) ad interim and conducted mid-year review meetings as well as meetings to discuss development plans.Led and managed all local FP&A activities of the German Management Entity.Analyzed and performed the commentaries of monthly and quarterly results and submitted the outcome to the global headquarters.

Led a sub-team (2 people) of the German FP&A team.Led all FP&A activities of the business units Cardiovascular & Metabolic, Neuroscience and Virology.Represented the Finance function in business unit, support function and brand team meetings by presenting and discussing financial results.Developed and maintained a local Alliance-Accounting-System to properly record and manage two Co-Promotion franchises (Cardiovascular & Metabolic) in collaboration with Astra Zeneca and with Pfizer.Developed and presented financial scenarios for product launches and market entries of generics to the business unit leadership team.Participated and contributed in various local and global Finance projects (e.g. Hyperion Planning improvement project).Ambassador of Global Finance GIVEs (Global Initiative for Volunteerism and Engagement) including a three weeks’ field work in South Africa and Zimbabwe.

Performed all activities regarding budgeting, forecasting and actual reporting of the business unit Primary Care including presentations of product sales and cost center performance to the business unit leadership team.Supported the implementation of new forecasting & reporting tools, e.g. SAP-BW.Supported a proper implementation of Internal Control and SOX processes in the German affiliate.

Coordinated the annual budget and quarterly forecasting process of the Marketing & Sales function in Germany in alignment with global timelines.Performed all activities regarding budgeting, forecasting and actual reporting of sales, gross margin and Marketing, Distribution & Administration cost centers.Performed consolidation and analysis of headcount planning data based on inputs from various departments.Prepared NPV-calculations for divestment and investment decisions of products and presented results to the German Finance Director.Prepared and established a forecasting & reporting system for an internal restructuring project.Performed all activities regarding budgeting, forecasting and actual reporting of “Preclinical Development” projects in terms of costs and headcounts (project & cost center controlling).Aligned local controlling processes with global processes for the Preclinical Development function after the acquisition of Aventis by Sanofi.

Supported the implementation of budgeting, forecasting and actual reporting tools (e.g. SAP R/2).Supported the process of cost center planning and P&L modelling of the service center.Prepared and presented various reports of the financial performance to the Service Center Management team.